The North America Medication Adherence Packaging market is expected to reach US$ 518.78 Mn in 2027 from US$ 304.78 Mn in 2018. The market is estimated to grow with a CAGR of 6.3% from 2019-2027.
The rising demand for medication adherence packaging, growing prevalence of chronic diseases and increasing government initiatives are the major driving factors that are estimated to grow the Medication Adherence Packaging market during the forecast period. However, the market is likely to experience slower growth due to high cost of installation and maintenance of medication adherence packaging systems.
There has been tremendous growth in chronic diseases in the region. Rising prevalence of the chronic disease is driving the medication adherence market. Medication adherence is widely used for chronic diseases, mainly for the medication of elderly patients, especially for long term diseases. Elderly patients are more prone to forget everyday drug dosage. Thus rising prevalence of chronic diseases like CVD, cancer, diabetes, and others drive the market growth.
Diabetes is one of the leading causes of global emergencies of the 21st century. The prevalence of the diseases is increasing year on year. For instance, in 2017, according to the International Diabetes Federation (IDF), in 2017, in North America, the number of people with diabetes were approximately 46 million, which is expected to grow at 62 million in 2045. The increase in disease prevalence is around 35% during the forecast period.
Also, according to the World Health Organization in 2018, cancer was the second leading cause of death across the globe and is responsible for an estimated 9.6 million deaths in 2018. Furthermore, the American Cancer Society estimated that in 2018, 1,735,350 new cancer cases were diagnosed in 2018.
The prescription of the chronic diseases demands at least a month-long drug administration and keep track of it. It is well known that the failure to follow the medication caused by non-medication adherence may lead to increased health care and treatment cost, treatment duration, and poor disease outcome. According to the World Health Organization (WHO), rates of medication non-adherence for any medication may vary from 15% to 93%. Medication non-adherence is a major clinical problem in the management of chronic illness.
Reasons to Buy
The rising demand for medication adherence packaging, growing prevalence of chronic diseases and increasing government initiatives are the major driving factors that are estimated to grow the Medication Adherence Packaging market during the forecast period. However, the market is likely to experience slower growth due to high cost of installation and maintenance of medication adherence packaging systems.
There has been tremendous growth in chronic diseases in the region. Rising prevalence of the chronic disease is driving the medication adherence market. Medication adherence is widely used for chronic diseases, mainly for the medication of elderly patients, especially for long term diseases. Elderly patients are more prone to forget everyday drug dosage. Thus rising prevalence of chronic diseases like CVD, cancer, diabetes, and others drive the market growth.
Diabetes is one of the leading causes of global emergencies of the 21st century. The prevalence of the diseases is increasing year on year. For instance, in 2017, according to the International Diabetes Federation (IDF), in 2017, in North America, the number of people with diabetes were approximately 46 million, which is expected to grow at 62 million in 2045. The increase in disease prevalence is around 35% during the forecast period.
Also, according to the World Health Organization in 2018, cancer was the second leading cause of death across the globe and is responsible for an estimated 9.6 million deaths in 2018. Furthermore, the American Cancer Society estimated that in 2018, 1,735,350 new cancer cases were diagnosed in 2018.
The prescription of the chronic diseases demands at least a month-long drug administration and keep track of it. It is well known that the failure to follow the medication caused by non-medication adherence may lead to increased health care and treatment cost, treatment duration, and poor disease outcome. According to the World Health Organization (WHO), rates of medication non-adherence for any medication may vary from 15% to 93%. Medication non-adherence is a major clinical problem in the management of chronic illness.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Medication Adherance Packaging Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Medication Adherance Packaging Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Medication Adherence Packaging- Market Landscape
5. Medication Adherence Packaging Market - Key Industry Dynamics
6. Medication Adherence Packaging Market - Regional Analysis
7. Medication Adherence Packaging Market Analysis And Forecasts To 2027 - System
8. Medication Adherence Packaging Market Analysis - To 2027 - Type
9. Medication Adherence Packaging Market Analysis And Forecasts To 2027 - Materials
10. Medication Adherence Packaging Market Revenue And Forecasts To 2027 - Regional Analysis
11. Medication Adherence Packaging Market -Industry Landscape
12. Medication Adherence Packaging Market-Key Company Profiles
13. Appendix
Samples
LOADING...
Companies Mentioned
A selection of companies mentioned in this report includes:
- McKesson Corporation
- Genoa
- WestRock Company
- Catalyst Healthcare Ltd.
- Omnicell, Inc.
- TCGRx (Parata Systems)
- Swisslog Holding AG (Talyst, LLC.)
- RxSafe, LLC
- Cardinal Health, Inc.
- Accu-Chart Plus